Modified natural nanoparticles as contrast agents for medical imaging.
about
Nanotechnology-mediated targeting of tumor angiogenesisNanoparticle contrast agents for computed tomography: a focus on micellesFuture of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis.Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.MRI stem cell tracking for therapy in experimental cerebral ischemia.Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.Poly(acrylic acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites as Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging.Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system.Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging.P22 viral capsids as nanocomposite high-relaxivity MRI contrast agentsExpanding coordination chemistry from protein to protein assembly.Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesCurrent and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions.Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesNanotoxicity comparison of four amphiphilic polymeric micelles with similar hydrophilic or hydrophobic structure.Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.Nanotoxicology: the molecular science point of view.Virus engineering: functionalization and stabilization.The application of nanoparticles in gene therapy and magnetic resonance imaging.Engineered nanoparticles for biomolecular imaging.Biological applications of magnetic nanoparticles.Principles and emerging applications of nanomagnetic materials in medicine.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Functionalization of protein-based nanocages for drug delivery applications.Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.Nanodiscs in Membrane Biochemistry and Biophysics.SPIO-RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation.Symmetry-Directed Design of Protein Cages and Protein Lattices and Their Applications.CuInSe/ZnS core/shell NIR quantum dots for biomedical imaging.Programmed Self-Assembly of a Biochemical and Magnetic Scaffold to Trigger and Manipulate Microtubule Structures.Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin.SV40 VP1 major capsid protein in its self-assembled form allows VP1 pentamers to coat various types of artificial beads in vitro regardless of their sizes and shapesUsing Nanoparticles in Medicine for Liver Cancer Imaging.Novel Biocompatible Au Nanostars@PEG Nanoparticles for In Vivo CT Imaging and Renal Clearance Properties.
P2860
Q21195857-A5850BBC-473D-4111-8F2C-6C58E5928A08Q26863316-8B2A512B-9FCD-4971-A293-2742CFAA9852Q30360777-9E0A6683-44E8-48C0-BAC5-F4347A32FB6FQ30426246-8C6404FF-A8EC-4502-ACE2-7B83708BE4F3Q30436623-27799ABD-321B-43B2-86DD-6BDB2121A8CAQ30712193-F2C912C1-F049-4CA8-AF5E-A0F2C60D063BQ30722696-E474D126-1099-46C3-BADD-07629BE9531FQ30978842-28D47044-7FF7-4CC6-A424-2CDE1F02A4EDQ33968665-C25F9952-E804-497B-9E1D-A6F1E8572E6CQ34204249-40A1D9C4-8EEA-49A7-9D6F-ED8497018C83Q34289410-3B11AF10-0F0F-4A68-843B-D307C1D9146EQ34315592-D0862A53-EE5E-4AF3-B62E-EF180BC3AC79Q34702892-C9BDBEF7-F41A-4BB5-A2D5-B54B253A0AF7Q35795262-7A4EA87E-8B22-42FB-9FDC-D081A41E3661Q36197710-4DF0C73D-83E4-4505-885C-E7AF8CADA98CQ36396054-0BF0D6F5-26C9-47F5-8680-587FC2D352DFQ36596084-92F36AAD-2C6A-48D2-A8D6-8C93F5B712A0Q36731084-70AD65BA-B1BA-4EF0-B657-D23DE85C92CEQ37078082-9E0B2522-1C4B-4EB3-B55C-323335BB525FQ37364457-9F7C5164-53F5-46C2-8EBC-DA3E2538B8AFQ37730633-81772E19-9EFE-45C6-86D8-7637A574E867Q37781310-85A7EE0D-3CCD-4169-9CF3-360DB99DBC78Q37798083-BE0F7EBE-6E55-4A87-AA7B-ADC5609AA6CAQ37864251-E09C7FD5-F82B-4EDD-AE16-BBBD55D226A2Q37895953-4C26ADD9-CE48-4CB7-AC96-9AFAB26EFB25Q38000520-3DDBBAA2-1F59-4F8B-8314-3A29BF57D1AEQ38001396-83B3DD84-3239-4FB5-A5D1-A1004998DFADQ38094125-B1ED6981-2912-42D3-A0ED-F9A75D692DF5Q38214775-B53B014F-F07C-490F-92AB-2B76FD327D3BQ38641476-6A5AD8B4-C318-45A4-9F42-A367D8D20D08Q38822339-5DBCC76A-97AC-4511-A210-40A92A2C6E44Q39126044-E9E8C0EA-478A-42D9-B78D-C01B7B0E74B9Q39521937-9A7A9278-6649-4BBF-BFB9-C5A3DA6B866AQ40303265-2776445F-59AB-4484-A1DC-AB62BB1EA2DCQ40460654-89A484F3-D7BE-4F79-8EEB-9B954D173B55Q41197364-8850419B-FC45-4CB8-8485-EB8F874C6D44Q42052611-5468EBCD-C4F0-4936-8633-E734D01B62EAQ42176740-3BECDCA4-A889-4F34-912A-A1D8D60D6A1EQ42339350-7A7D6045-A916-4A3A-9A47-38F5515ECC4EQ42653104-594B0A51-FBC0-4FE6-9839-B9267DD1C4B0
P2860
Modified natural nanoparticles as contrast agents for medical imaging.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Modified natural nanoparticles as contrast agents for medical imaging.
@en
Modified natural nanoparticles as contrast agents for medical imaging.
@nl
type
label
Modified natural nanoparticles as contrast agents for medical imaging.
@en
Modified natural nanoparticles as contrast agents for medical imaging.
@nl
prefLabel
Modified natural nanoparticles as contrast agents for medical imaging.
@en
Modified natural nanoparticles as contrast agents for medical imaging.
@nl
P2860
P1476
Modified natural nanoparticles as contrast agents for medical imaging
@en
P2093
Peter A Jarzyna
Zahi A Fayad
P2860
P304
P356
10.1016/J.ADDR.2009.11.005
P407
P577
2009-11-06T00:00:00Z